New guidelines, growth opportunities, and investment in new technologies

Our Press & Policy

Stay up to date with the latest IVD sector news and developments in health policy.

Mar 29, 2023
The North East Innovation Lab, part of Newcastle Hospitals has achieved a major milestone with accreditation to an international standard. The lab has been awarded accreditation by UKAS to ISO 15189 for SARS-CoV-2 testing which assesses not only the testing carried out by the lab, but also the quality management system required to ensure the laboratory operates to the highest standards.
Read More
Mar 20, 2023
Oxford Cancer Biomarkers (OCB) and OncoHelix today announce a new partnership to offer OCB’s advanced genetic test in Canada for screening and detection of people at risk for colorectal cancer.
Read More
Feb 03, 2023
The Department of Health and Social Care published the first strategy for medical technology today. The British In Vitro Diagnostics Association (BIVDA) welcomes this as another step forward to achieving wider use of the essential diagnostic tests and enabling technology which can really support better healthcare for patients and save resource for the NHS.
Read More
Feb 02, 2023
In this blog, Doris-Ann examines the pandemic’s legacy of normalising diagnostic testing and how we should use this opportunity to be more health aware as a society.
Read More
Jan 30, 2023
Doris-Ann has provided a simple explainer to help companies better understand the NHS Innovation Service and how best to use it.
Read More
Jan 10, 2023
The North East Innovation Lab is celebrating a two-year milestone birthday and has expanded its work in accelerating the development of diagnostics for a range of virus and health threats.
Read More
Nov 30, 2022
Breakthrough SAMBA II point-of-care diagnostic machine on show to the public from this November, as part of inspiring COVID-19 science showcase.
Read More
Nov 24, 2022
RQM+, the leading MedTech service provider with the world’s largest global team of regulatory and quality experts, today announced the launch of its reimbursement division. RQM+ now provides comprehensive reimbursement services in addition to regulatory, quality, clinical and laboratory services – supporting market access throughout the entire product lifecycle for medical devices and diagnostics.
Read More
Sep 23, 2022
Chancellor Kwasi Kwarteng has today unveiled his new Growth Plan in Parliament – we will provide a full summary, and what it means for the life sciences industry, next week. Among the flagship tax cuts on income tax and the cancellation of corporation tax rises, the Chancellor also pledged to provide up to £500 million to support new innovative funds and attract billions of additional pounds into UK science and technology scale-ups.
Read More
Sep 23, 2022
In his first major act as Secretary of State for Business, Energy and Industrial Strategy, Jacob Rees-Mogg has announced a new scheme which aims to steer British business through a tough winter, owing to the gas crisis caused by Russia’s invasion of Ukraine.
Read More
Page 3 of 34 [3]

Interested in becoming a member? Join us!

Copyright 2024 BIVDA Ltd is registered in England
Company Number 2687137
Registered Office is 299 Oxford Street (5th floor),
London, W1C 2DZ. VAT Number 563105858